Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 609-616

  Hilakivi Clarke, Leena ^a,b   Cho, Elizabeth ^a   Clarke, Robert ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Estradiol; Genistein; In utero exposure; Mammary gland; Tamoxifen; Zearalenone

Indexed keywords

GENISTEIN; ZEARALENONE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; ESTROGEN METABOLISM; FEMALE; HORMONAL CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031970216     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.609     Document Type: Article

References (72)

1. Walker BE: Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high-fat diets. J Natl Cancer Inst 82: 50-54, 1990.
2. Lopez J, Ogren L, Verjan R and Talamantes F: Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology 38: 129-334, 1988.
3. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E and Lippman ME: A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 94: 9372-9377, 1997.
4. Hilakivi-Clarke L, Cho E, Raygada M and Kenney N: Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182, 780. J Cell Physiol 170: 279-289, 1997.
5. Jones LA and Bern HA: Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination. Cancer Res 39: 2560-2567, 1979.
6. Hilakivi-Clarke LA, Raygada M, Stoica A and Martin M-B: Consumption of a high-fat diet during pregnancy alters estrogen receptor content, protein kinase C activity and morphology of mammary gland in the mother and her female offspring. Cancer Res (In press).
7. Nelson KG, Sakai Y, Eitzman B, Steed T and McLachlan J: Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5: 595-606, 1994.
8. Gerhard I, Vollmar B, Runnebaum B, Klinga K, Haller U and Kubli F: Weight percentile at birth: II prediction by endocrinological and sonographic measurements. Eur J Obstet Gyn Reprod Biol 26: 313-328, 1987.
9. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter D, Colditz GA, Hankinson SE, Speizer FE and Willett WC: Birthweight as a risk factor for breast cancer. Lancet 348: 1542-1546, 1996.
10. Sanderson M, Williams M, Malone KE, Stanford JL, Emanuel I, White E and Daling JR: Perinatal factors and risk of breast cancer. Epidemiology 7: 34-37, 1996.
11. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC and Lan SJ: Evidence of prenatal influences on breast cancer risk. Lancet 340: 1015-1018, 1992.
12. Ekbom A, Hsieh CC, Lipworth L, Adami HO and Trichopoulos D: Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 89: 71-76, 1997.
13. Adlercreutz H, Mousavi Y, Clark J, Hockerstedt K, Hamalainen E, Wahala K, Makela T and Hase T: Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 41: 331-337, 1992.
14. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustaffson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
15. Wang TT, Sathyamoorthy N and Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275, 1996.
16. Santell RC, Chang YC, Nair MG and Helferich WG: Dietary genistein exerts estrogeneic effects upon the uterus, mammary gland and the hypothalamic/pityuitary axis in rats. J Nutr 127: 263-269, 1997.
17. Cassidy A, Bingham S and Setchell KDR: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60: 333-340, 1994.
18. Wilcox G, Wahlqvist ML, Burger HG and Medley G: Oestrogenic effects of plant foods in postmenopausal women. BMd J 301: 905-906, 1990.
19. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, Weinberg CR, Haney AF, Wilcox AJ and McLachlan JA: Dietary intervention study to assess estrogenity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80: 1685-1690, 1995.
20. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M and Coward L: Stimulatory influence of soy protein isolate on breast secretion in pre- and post-menopausal women. Cancer Epidem Biomarker Prev 5: 785-794, 1996.
21. Setchell KDR, Zimmer-Nechemias L, Call J and Heubi JE: Exposure of infants to phytoestrogens from soy-based infant formula. Lancet 350: 23-27, 1997.
22. Hagler WM, Tyczkowska K and Hamilton PB: Simultaneous occurrence of deoxynivalenol, zearalenone, and aflatoxin in 1982 scabby wheat from the Midwestern United States. Appl Environ Microbiol 47: 151-154, 1984.
23. Luo Y, Yoshizawa T and Katayama T: Comparative study on the natural occurrence of fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol 56: 3723-3726, 1990.
24. Hidy PH and Baldwin RS: Method of preventing pregnancy with lactone derivates. US Pat June 22: 3,966,274, 1976.
25. Utian WH: Comparative trial of P-1496, a new non-steroidal oestrogen analogue. BMJ 1: 579-581, 1973.
26. Ralston AT: Effect of zearalanol on weaning weight of male calves. J Anim Sci 47: 1203-1206, 1978.
27. Wiggins JP, Rothenbacher H, Wilson LL, Martin RJ, Wangness PJ and Ziegler JH: Growth and endocrine responses of lambs to zearanol implants: effects of preimplant growth rate and breed of sire J Anim Sci 49: 291-297, 1979.
28. Martin PM, Horwitz KB, Ryan DS and McGuire W: Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103: 1860-1867, 1978.
29. Schoental R: Role of podophyllotoxin in the bedding and dietary zearalenone on incidence of 'spontaneous' tumors in laboratory animals. Cancer Res 34: 2419, 1974.
30. Schoental R: Trichoihecenes, zearalenone, and other carcinogenic metabolites of fusarium and related microfungi. Adv Cancer Res 45: 217-290, 1985.
31. Anbazhagan R, Bartek J, Monaghan P and Gusterson BA: Growth and development of the human infant breast. Am J Anat 192: 407-417, 1991.
32. Imagawa W, Bandyopadhyay GK and Nandi S: Regulation of mammary epithelial cell growth in mice and rats. Endocrine Rev 11: 494-523, 1990.
33. Daniel CW and Silberstein GB (eds): Postnatal development of the rodent mammary gland. In: The Mammary Gland: Development, Regulation, and Function. Plenum Press, New York, 1987.
34. Russo J and Russo IH: Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112-137, 1987.
35. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary rumorisenesis. Lab Invest 62: 244-278, 1990.
36. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH and Merlino GT: TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137-1146, 1990.
37. Krane IM and Leder P: NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammay glands of transgenic mice. Oncogene 12: 1781-1788, 1996.
38. Burroughs CD, Mills KT and Bern HA: Reproductive abnomalities in female mice exposed neonatally to various doses of coumestrol. J Toxicol Environ Health 30: 105-122, 1990.
39. Talamantes F and Browing HC: Effect of neonatal administration of norethynodrelmestranol on the reproductive system of female mice. Tex Rep Biol Med 30: 361-369, 1972.
40. Messina M, Persky V, Setchell KDR and Barnes S: Soy intake and breast cancer: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131, 1994.
41. Kuiper-Goodman T: Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can J Physiol Pharmacol 68: 1017-1024, 1990.
42. Mayr U, Butsch A and Schneider S: Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 74: 135-149, 1992.
43. Eckstein B, Golan R and Shani J: Onset of puberty in the immature female rat induced by 5alpha-androstane-3beta, 17beta-diol. Endocrinology 92: 941-945, 1973.
44. Haslam SZ: Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122: 464-470, 1988.
45. Villar J, Cogswell M, Kestler E, Castillo P, Menendez R and Repke JT: Effect of fat and fat-free mass deposition during pregnancy on birth weight. Am J Obstet Gynecol 167: 1344-1352, 1992.
46. Susser M: Maternal weight gain, infant birth weigh, and diet: causal consequences. Am J Clin Nutr 53: 1384, 1990.
47. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, Hamalainen E, Markkanen MH, Makela TH, Wahala KT, Hase TA and Fotsis T: Soybean phytoestrogen intake and cancer risk. J Nutr 125: 757S-770S, 1996.
48. Murrill WB, Brown NM, Zhang IX, Manzolillo PA, Barnes S and Lamartiniere CA: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457, 1996.
49. Barnes S: Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125: 777S-783S, 1995.
50. Akiyama T, Ishida J, Nakagawa S, Ogawa H, Watanabe S, Itou N, Shibata M and Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinease. J Biol Chem 262: 5592-5595, 1987.
51. Okura A, Arakawa H, Oka H, Yoshinari T and Monden Y: Effect of genistein on topoisomerase activity and on the growth of (val 12) Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157: 183-189, 1988.
52. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R and Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90: 2690-2694, 1993.
53. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE: Dietary effects on breast cancer risk in Singapore. Lancet 337: 1197-1200, 1991.
54. Nomura A, Henderson BE and Lee J: Breast cancer and diet among the Japanese in Hawaii. Am J Clin Nutr 31: 2020-2025, 1978.
55. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AMY, West DW, Kolonel LN, Rosenthal JF, Hoover RN and Pike MC: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidem Biomarker Prev 5: 901-906, 1996.
56. Hirohata T, Shigematsu T, Nomura AMY, Nomura Y, Horie A and Hirohata I: Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69: 187-190, 1985.
57. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A and Haile RW: Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat 42: 243-251, 1997.
58. Yuan JM, Wang QS, Ross RK, Henderson BE and Yu MC: Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353-1358, 1995.
59. Ingram D, Sanders K, Kolybaba M and Lopez D: Case-control study of phytoestrogens and breast cancer. Lancet 350: 990-994, 1997.
60. Wakshlak A and Weinstock M: Neonatal handling reverses behavioral abnormalities induced by prenatal stress. Physiol Behav 48: 289-292, 1990.
61. Sato T, Ohta Y, Okamura H, Hayashi S and Iguchi T: Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol. Anat Rec 244: 374-385, 1966.
62. Kiang DT, Kennedy BJ, Pathre SV and Mirocha CJ: Binding characteristics of zearalenone analogs to estrogen receptors. Cancer Res 38: 3611-3615, 1978.
63. Mayr UE: Estrogen-controlled gene expression in tissue culture cells by zearalenone. FEBS Lett 239: 223-226, 1988.
64. Ito Y and Ohtsubo K: Effects of neonatal administration of zearalenone on the reproductive physiology of female mice. J Vet Med Sci 56: 1155-1159, 1994.
65. Williams BA, Mills KT, Burroughs CD and Bern HA: Reproductive alterations in female C57BL/Crgl mice exposed neonatally to zearalenone, an estrogenic mycotoxin. Cancer Lett 46: 225-230, 1989.
66. Smith JM, Sporn MB, Roberts AB, Derynck R, Winkler ME and Gregory H: Human transforming growth factor a causes precocious eyelid opening in newborn mice. Nature 315: 515-516, 1985.
67. Levy JR, Faber KA, Ayyash L and Hughers CLJ: The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med 208: 60-66, 1995.
68. Burroughs CD, Bern HA and Stokstad ELR: Prolonged vaginal cornification and other changes in mice treated neonatally with coumestrol, a plant estrogen. J Toxicol Environ Health 15: 51-61, 1985.
69. Holderegger C and Keefer D: The ontogeny of the mouse estrogen receptor: the pelvic region. Am J Anat 177: 285-297, 1986.
70. Dotzlaw H, Leygue E, Watson PH and Murphy LC: Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374, 1996.
71. Lu L-JW, Anderson KE, Grady JJ and Nagamani M: Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidem Biomarker Prev 5: 63-70, 1996.
72. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF and Hyer MB: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85: 1819-1827, 1993.